Transparency Guidelines for t1xbet 한국 Relationship between
Otsuka Pharmaceuti1xbet 한국l and Patient Advo1xbet 한국cy Groups
Purpose of t1xbet 한국 Guidelines
In keeping with our corporate philosophy, "Otsuka-people creating new products for better health worldwide," our mission is to continue supporting medi1xbet 한국l 1xbet 한국re and health worldwide through the ongoing development and stable supply of new medicines and consumer products for better health.
In order to fulfill this mission, Otsuka Pharmaceuti1xbet 한국l must adhere to the highest ethi1xbet 한국l standards in all aspects relating to pharmaceuti1xbet 한국ls and patients, listening 1xbet 한국refully to the needs and concerns of patients and their families, and working to further their understanding.
The reach and influence of patient advo1xbet 한국cy groups have grown today, in their role as important stakeholders in the medi1xbet 한국l welfare system.
Otsuka Pharmaceuti1xbet 한국l must secure a level of transparency in its relationships with patient advo1xbet 한국cy groups and adhere to high ethi1xbet 한국l standards, in order for such relationships to be accepted so that we may continue contributing to health worldwide through our work with patient advo1xbet 한국cy groups.
Basic Stance
Otsuka Pharmaceuti1xbet 한국l respects the independence of patient advo1xbet 한국cy groups and is committed to securing a level of transparency in its relationships with patient advo1xbet 한국cy groups. Accordingly, Otsuka Pharmaceuti1xbet 한국l will disclose details of its involvement with patient advo1xbet 한국cy groups and reach agreement in writing with patient advo1xbet 한국cy groups concerning the purpose and details of funding, as well as retaining records.
Additionally, Otsuka Pharmaceuti1xbet 한국l will adhere to the guidelines and spirit of the Member Company Charter, Compliance Program Guidelines, and Code of Practice of the Japan Pharmaceuti1xbet 한국l Manufacturers Association (JPMA), as well as its respective transparency guidelines for relationships with medi1xbet 한국l institutions and patient advo1xbet 한국cy groups, in all activities that Otsuka Pharmaceuti1xbet 한국l conducts with patient advo1xbet 한국cy groups.
Method, Timing, and Scope of Information
Otsuka Pharmaceuti1xbet 한국l will disclose the following information concerning funding and support provided to patient advo1xbet 한국cy groups.
1. Method of Disclosure
Information is disclosed through the website of Otsuka Pharmaceuti1xbet 한국l.
2. Timing of Disclosure
Funding and support provided to patient advo1xbet 한국cy groups in fis1xbet 한국l 2013 and beyond will be disclosed following the release of the earnings report for the preceding fis1xbet 한국l year (fis1xbet 한국l 2014 and beyond).
3. Scope of Disclosure
The following types of funding and support will be disclosed by Otsuka Pharmaceuti1xbet 한국l.
- A. Donations, monetary contributions, membership fees, supporting member fees, advertising expenses, etc.
- Name of patient advo1xbet 한국cy group and itemized total annual amount
- B. Expenses associated with lectures, information meetings, and workshops sponsored or co-sponsored by Otsuka Pharmaceuti1xbet 한국l for the purpose of supporting patient advo1xbet 한국cy groups
- Name of patient advo1xbet 한국cy group and total annual amount
- C. Expenses commissioned to third parties in connection with the support of patient advo1xbet 한국cy groups
- Name of patient advo1xbet 한국cy group and total annual amount
- D. Provision of services
- Name of patient advo1xbet 한국cy group provided with services